Printer Friendly

ANERGEN REPORTS THIRD QUARTER RESULTS

 REDWOOD CITY, Calif., Oct. 21 /PRNewswire/ -- Anergen Inc. (NASDAQ: ANRG) today reported a net loss of $1,950,000, or ($.31) per share, for the third quarter ended Sept. 30, 1993, as compared to a loss of $1,446,000, or ($.26) per share, for the same period a year ago. Anergen's loss for the nine-month period ended Sept. 30, 1993, was $5,302,000, or ($.91) per share, as compared to a loss of $3,820,000, or ($.68) per share, for the nine months ended Sept. 30, 1992.
 John W. Varian, Anergen's chief financial officer, said "The company's scientific program is progressing on schedule and at planned spending levels. The increase in expenditures reflects the costs of production in our pilot manufacturing facility, and certain costs associated with our recently completed corporate alliance with Novo Nordisk A/S. Anergen will begin receiving revenues under this agreement in this fourth quarter of 1993."
 Anergen is developing therapies for the treatment of autoimmune diseases using proprietary biopharmaceutical compounds designed to inactivate or anergize only the specific T cells in the immune system responsible for each disease.
 ANERGEN INC.
 Unaudited Selected Financial Data
 (In thousands except per share data)
 Three Months Ended Nine Months Ended
 Sept. 30, Sept. 30,
 1993 1992 1993 1992
 Operations data
 Expenses:
 Research and development $1,498 $1,128 $4,061 $3,032
 General and administrative 421 427 1,224 1,148
 Interest, net 31 (109) 17 (360)
 Net loss $1,950 $1,446 $5,302 $3,820
 Net loss per share $0.31 $0.26 $0.91 $0.68
 Shares used in calculating
 per share data 6,210 5,599 5,845 5,585
 Sept. 30, Dec. 31,
 1993 1992
 Balance sheet data
 Cash and short-term investments $11,281 $8,918
 Working capital 9,837 7,234
 Total assets 13,089 10,724
 Total liabilities 2,330 2,867
 Shareholders' equity 10,759 7,857
 -0- 10/21/93
 /CONTACT: Joan Shield, investor relations, or John Varian, CFO, of Anergen, 415-361-8901; or Kimberly Kraemer or Mark Brand of Pondel Parsons & Wilkinson, 310-207-9300/
 (ANRG) CO: Anergen Inc. ST: California IN: MTC SU: ERN


JL-LM -- LA004 -- 5589 10/22/93 09:00 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 22, 1993
Words:365
Previous Article:COMPUTER PRODUCTS REPORTS THIRD QUARTER RESULTS
Next Article:ALLIED GROUP, INC. REPORTS RECORD NINE-MONTH EARNINGS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters